The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
- Oral Liver Diseases Therapeutics Drugs
- Injection Liver Diseases Therapeutics Drugs
Segment by Application
By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
By Company
- F. Hoffmann-La Roche
- Gilead Sciences
- GlaxoSmithKline
- Johnson & Johnson
- Merck
- Achillion Pharmaceuticals
- AbbVie
- Angion Biomedica
- Bayer
- LG Life Sciences
- Phenex Pharmaceuticals
- ProMetic Life Sciences
- Raptor Pharmaceuticals
- Shenzhen Kangtai Biological Products
- Verva Pharmaceuticals
